Skip to main content

New lab up for the fight

A new biosecure immunology lab heralds a new era in the battle against infectious disease.

Discovery signals malaria downfall

Deakin researchers have discovered a gateway that could lead to the eradication of malaria.

Making a difference

Neil Archbold Memorial travel awards presented to PhD researchers.

Metabolic Research Unit

Overview

The Metabolic Research Unit (MRU) is a purpose-built molecular facility located on Deakin's Waurn Ponds Campus. It supports research focussed on the causes and characterisation of complex metabolic diseases including obesity and type 2 diabetes, with additional programs investigating the role of metabolism in mood disorders and muscular dystrophy. There is strong expertise in glucose and lipid metabolism, and a particular emphasis on the role of mitochondria in metabolic diseases, with focus on pre-clinical development of novel therapeutics.

Capabilities

The MRU houses strong platforms in cell culture and molecular biology, utilising cutting edge technologies in conjunction with unique model systems to discover novel factors involved in the development of obesity, type 2 diabetes and other disorders. This knowledge is then used to investigate novel compounds that may be developed as drugs to treat these diseases.

Key Infrastructure

  • PC2 labs
  • MiSeq Next-generation sequencing
  • Biolane HTI 16V in situ detection system
  • Seahorse mitochondrial flux analyser
  • EchoMRI
  • Echocardiograph
  • Histology core facility
  • Microscopy suite

Deakin University acknowledges the traditional land owners of present campus sites.

27th February 2015